Gilenya Drug

Listing Websites about Gilenya Drug

Filter Type:

Pill for RRMS Treatment I GILENYA® (fingolimod)

(4 days ago) GILENYA may cause serious side effects such as: Slow heart rate, especially after first dose. Adults and children will be monitored by a health care professional for at least 6 hours after the …

Url: Visit Now

Category:  Health,  Heart Detail Drugs


Gilenya: 7 things you should know - Drugs.com

(7 days ago) Gilenya is known as a disease-modifying drug and it reduces the number of relapses of multiple sclerosis (MS) by about half (50%). Any relapses that do happen should be less severe. It …

Url: Visit Now

Category:  Health Detail Drugs


Gilenya oral: Uses, Side Effects, Interactions, Pictures - WebMD

(2 days ago) Find patient medical information for Gilenya oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Url: Visit Now

Category:  Health Detail Drugs


Gilenya for MS: How it works, side effects, and more - Medical …

(2 days ago) Gilenya (fingolimod) is a prescription brand-name medication. It’s approved by the Food and Drug Administration (FDA) to treat the following relapsing forms of multiple sclerosis (MS

Url: Visit Now

Category:  Health Detail Drugs


Gilenya (Fingolimod Capsules): Uses, Dosage, Side Effects - RxList

(9 days ago) Gilenya belongs to a class of drugs called Immunomodulators; Multiple Sclerosis Treatments; Sphingosine 1-Phosphate Receptor Modulators. It is not known if Gilenya is safe and effective …

Url: Visit Now

Category:  Health Detail Drugs


Gilenya Interactions with Other Medication - WebMD

(Just Now) Serious Interactions. These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation. …

Url: Visit Now

Category:  Medications,  Doctor,  Health Detail Drugs


Fingolimod - Wikipedia

(Just Now) Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor …

Url: Visit Now

Category:  Health Detail Drugs


Gilenya National Multiple Sclerosis Society

(5 days ago) Gilenya was approved by the U.S. Food and Drug Administration (FDA) for treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting …

Url: Visit Now

Category:  Health Detail Drugs


Supreme court throws Novartis a lifeline for Gilenya defense

(1 days ago) Gilenya was first approved in 2010 and has been a big brand for Novartis, although it is facing strong competition from newer drugs such as Roche’s Ocrevus (ocrelizumab), Merck KGaA’s

Url: Visit Now

Category:  Health Detail Drugs


Gilenya dosage: Form, strengths, how to use, and more - Medical …

(2 days ago) Gilenya (fingolimod) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat relapsing forms of multiple sclerosis in adults and children ages …

Url: Visit Now

Category:  Health Detail Drugs


U.S. Supreme Court grants Novartis request to halt Gilenya generic

(4 days ago) Novartis reported nearly $2.8 billion in Gilenya sales last year, making it the Swiss company's third-highest-selling drug. Novartis said last week that it expects to lose $300 million in sales

Url: Visit Now

Category:  Health Detail Drugs


Gilenya Side Effects: What They Are and How to Manage Them

(Just Now) The active drug in Gilenya is fingolimod. (This is the ingredient that makes the medication work). Fingolimod is also the name of the generic version of Gilenya.

Url: Visit Now

Category:  Health Detail Drugs


Gilenya (Fingolimod): Side Effects, for MS, Costs, and More

(7 days ago) Learn about side effects, uses, costs, and more of Gilenya (fingolimod). It’s a prescription drug that treats multiple sclerosis in adults and some children.

Url: Visit Now

Category:  Health Detail Drugs


Novartis (NYSE: NVS) Wins Reprieve From U.S. Supreme Court …

(2 days ago) On Thursday, Novartis won a reprieve from the U.S. Supreme Court after it put on hold the cancellation of some of Novartis’ patents on the dosage regimen for its multiple sclerosis drug …

Url: Visit Now

Category:  Health Detail Drugs


Supreme Court grants Novartis request to halt Gilenya patent

(6 days ago) Novartis. The U.S. Supreme Court on Thursday agreed to halt the cancelation of a key patent for Novartis’ multiple sclerosis drug Gilenya, staving off a wave of competition from at least a …

Url: Visit Now

Category:  Health Detail Drugs


An MS Drug Takes a Feisty Approach Aimed at Younger Patients

(5 days ago) April 3, 2013. THE Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its “Hey MS, Take This!” campaign shows patients

Url: Visit Now

Category:  Health Detail Drugs


F.D.A. Approves Novartis’s Gilenya, a Treatment for M.S. - The New …

(9 days ago) Novartis said Gilenya reduced the frequency of M.S. relapses and helped to slow the advance of some of the physical problems caused by the disease, and the drug had a well-studied safety …

Url: Visit Now

Category:  Health Detail Drugs